{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:19Z","timestamp":1786119379097,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/cad.0b013e328333d679","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T10:46:45Z","timestamp":1261392405000},"page":"206-209","source":"Crossref","is-referenced-by-count":35,"title":["Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib"],"prefix":"10.1097","volume":"21","author":[{"given":"Caroline","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Brade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006","volume":"54","author":"Hymes","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-4632.2004.02406.x","article-title":"Radiation recall dermatitis","volume":"43","author":"Ristic","year":"2004","journal-title":"Int J Dermatol"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clon.2008.11.001","article-title":"Chemotherapy-induced recall of cetuximab and radiation skin reaction","volume":"21","author":"Law","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1155\/2009\/307894","article-title":"Radiation recall reaction induced by adjuvant trastuzumab (herceptin)","volume":"2009","author":"Chung","year":"2009","journal-title":"Case Report Med"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clon.2009.03.003","article-title":"Trastuzumab-induced radiation recall dermatitis -- first reported case","volume":"21","author":"Shrimali","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","year":"2006","journal-title":"J Clin Oncol"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2133.2007.08357.x","article-title":"Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy","volume":"158","author":"Yang","year":"2008","journal-title":"Br J Dermatol"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/0044011-200929010-00007","article-title":"Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma","volume":"29","author":"Hsieh","year":"2009","journal-title":"Clin Drug Investig"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/120347540200600603","article-title":"Histopathologic features seen with radiation recall or enhancement eruptions","volume":"6","author":"Smith","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.24.4.544","article-title":"The effect of actinomycin D on cancer in childhood","volume":"24","author":"Tan","year":"1959","journal-title":"Pediatrics"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation recall: a well recognized but neglected phenomenon","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.1995.13.1.305","article-title":"Radiation-recall dermatitis in a patient treated with paclitaxel","volume":"13","author":"Phillips","year":"1995","journal-title":"J Clin Oncol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328333d679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:48Z","timestamp":1786039848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-201002000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328333d679","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}